|
The history of AIDS (Acquired Immunodeficiency Syndrome), with timelines, photos, and links to resources on the Internet. Endeavoring to raise public awareness through understanding.
|
|
The History of AIDS: Timeline of the History of HIV/AIDS: 2001 2001 On January 5, 2001, FDA and Bristol Myers Squibb Issued Caution for HIV Combination Therapy with Zerit and Videx in Pregnant Women On July 20, 2001, a scientific review panel confirms Condoms Are Effective Against HIV/AIDS, but epidemiological studies are insufficient for other STDs On July 26, 2001, FDA approved the Stand-Alone (Unbundled) Package for Rebetol Capsules for use with Intron A for the treatment of chronic hepatitis C infection, On September 21, 2001, FDA licensed the First Nucleic Acid Test (NAT) systems to Screen Plasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). Nucleic acid test (NAT) systems intended for screening of plasma donors. These test systems are expected to further ensure the safety of plasma-derived products by permitting earlier detection of HIV and HCV infections in donors On September 26, 2001 FDA approved Visible Genetics, Inc., TrueGene HIV-1 Genotyping Kit and Open Gene DNA Sequencing System to be used to identify drug resistance in HIV patients. (Approval Information) On October 26, 2001 Viread (tenofovir disoproxil fumarate) received accelerated approval on for treatment of HIV-1 infection in combination with other antiretroviral medicines. Viread is the first nucleotide analog approved for HIV-1 treatment. Nucleotides are similar to nucleoside analogs, and block HIV replication in the same manner. Viread is manufactured by Gilead Sciences. Approval Letter [PDF format] | Package Insert [PDF format] On November 19, 2001, FDA approved NucliSens HIV-1 QT, made by bioMerieux, Inc., Durham, NC, PMA number: BP010001/0. The Indication for Use is: in conjunction with clinical presentation and other laboratory markers of disease progression for prognostic assessment of HIV-1 infected patients, and for monitoring the effects of anti-retroviral therapy by serial easurements of plasma HIV-1 RNA for pediatric and adult patients with baseline viral loads greater than 93,000 and 28,000 copies of HIV-1 viral RNA/mL respectively. 2000 ...Last ||| Next... 2002 |